Walsh DM - Search Results

1

Soluble oligomers for the diagnosis of neurodegenerative diseases.

El-Agnaf OM, Walsh DM, Allsop D. El-Agnaf OM, et al. Among authors: walsh dm. Lancet Neurol. 2003 Aug;2(8):461-2. doi: 10.1016/s1474-4422(03)00481-2. Lancet Neurol. 2003. PMID: 12878433 Review. No abstract available.

2

Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ. Walsh DM, et al. J Neurosci. 2005 Mar 9;25(10):2455-62. doi: 10.1523/JNEUROSCI.4391-04.2005. J Neurosci. 2005. PMID: 15758153 Free PMC article.

3

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases.

Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM. Irvine GB, et al. Among authors: walsh dm. Mol Med. 2008 Jul-Aug;14(7-8):451-64. doi: 10.2119/2007-00100.Irvine. Mol Med. 2008. PMID: 18368143 Free PMC article. Review.

4

The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms.

O'Dowd ST, Ardah MT, Johansson P, Lomakin A, Benedek GB, Roberts KA, Cummins G, El Agnaf OM, Svensson J, Zetterberg H, Lynch T, Walsh DM. O'Dowd ST, et al. Among authors: walsh dm. J Alzheimers Dis. 2013;33(4):923-8. doi: 10.3233/JAD-2012-121393. J Alzheimers Dis. 2013. PMID: 23034520

5

Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.

Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O'Hare E, Walsh DM, Selkoe DJ. Townsend M, et al. Among authors: walsh dm. Ann Neurol. 2006 Dec;60(6):668-76. doi: 10.1002/ana.21051. Ann Neurol. 2006. PMID: 17192927

6

Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.

Walsh DM, Selkoe DJ. Walsh DM, et al. Protein Pept Lett. 2004 Jun;11(3):213-28. doi: 10.2174/0929866043407174. Protein Pept Lett. 2004. PMID: 15182223 Review.

7

A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.

Xia W, Yang T, Shankar G, Smith IM, Shen Y, Walsh DM, Selkoe DJ. Xia W, et al. Among authors: walsh dm. Arch Neurol. 2009 Feb;66(2):190-9. doi: 10.1001/archneurol.2008.565. Arch Neurol. 2009. PMID: 19204155 Free PMC article.

8

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, Trojanowski JQ, Blennow K. Hampel H, et al. Among authors: walsh dm. Exp Neurol. 2010 Jun;223(2):334-46. doi: 10.1016/j.expneurol.2009.09.024. Epub 2009 Oct 6. Exp Neurol. 2010. PMID: 19815015 Free PMC article. Review.

9

Soluble Aβ aggregates can inhibit prion propagation.

Sarell CJ, Quarterman E, Yip DC, Terry C, Nicoll AJ, Wadsworth JDF, Farrow MA, Walsh DM, Collinge J. Sarell CJ, et al. Among authors: walsh dm. Open Biol. 2017 Nov;7(11):170158. doi: 10.1098/rsob.170158. Open Biol. 2017. PMID: 29142106 Free PMC article.

10

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Walsh DM, et al. Biochem Soc Trans. 2002 Aug;30(4):552-7. doi: 10.1042/bst0300552. Biochem Soc Trans. 2002. PMID: 12196135 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page